China Pharma Holdings, Inc. (CPHI)
USD 1.91
(-3.54%)
USD 1.91
(-3.54%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.73 Million USD | 26.69% |
| 2022 | 2.94 Million USD | -11.73% |
| 2021 | 3.33 Million USD | -9.86% |
| 2020 | 3.7 Million USD | 3.24% |
| 2019 | 3.58 Million USD | -29.0% |
| 2018 | 5.05 Million USD | -21.1% |
| 2017 | 6.4 Million USD | -12.36% |
| 2016 | 7.31 Million USD | -24.34% |
| 2015 | 9.66 Million USD | -36.93% |
| 2014 | 15.32 Million USD | -37.91% |
| 2013 | 24.67 Million USD | -32.13% |
| 2012 | 36.35 Million USD | 19.69% |
| 2011 | 30.37 Million USD | 49.0% |
| 2010 | 20.38 Million USD | 43.25% |
| 2009 | 14.23 Million USD | 8.32% |
| 2008 | 13.13 Million USD | -9.06% |
| 2007 | 14.44 Million USD | 40.58% |
| 2006 | 10.27 Million USD | 77.66% |
| 2005 | 5.78 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.67 Million USD | -1.49% |
| 2024 Q2 | 2.81 Million USD | -23.37% |
| 2023 Q3 | 3.76 Million USD | -3.74% |
| 2023 Q1 | 3.76 Million USD | 27.57% |
| 2023 Q2 | 3.91 Million USD | 4.07% |
| 2023 FY | 3.73 Million USD | 26.69% |
| 2023 Q4 | 3.73 Million USD | -0.86% |
| 2022 FY | 2.94 Million USD | -11.73% |
| 2022 Q4 | 2.94 Million USD | 2.1% |
| 2022 Q2 | 3.53 Million USD | -9.62% |
| 2022 Q1 | 3.9 Million USD | 16.97% |
| 2022 Q3 | 2.88 Million USD | -18.23% |
| 2021 Q1 | 3.66 Million USD | -1.15% |
| 2021 Q2 | 2.97 Million USD | -18.68% |
| 2021 Q3 | 3.07 Million USD | 3.22% |
| 2021 Q4 | 3.33 Million USD | 8.65% |
| 2021 FY | 3.33 Million USD | -9.86% |
| 2020 Q3 | 3.51 Million USD | -8.81% |
| 2020 FY | 3.7 Million USD | 3.24% |
| 2020 Q1 | 3.62 Million USD | 1.01% |
| 2020 Q2 | 3.85 Million USD | 6.29% |
| 2020 Q4 | 3.7 Million USD | 5.45% |
| 2019 Q4 | 3.58 Million USD | -9.68% |
| 2019 Q1 | 4.93 Million USD | -2.39% |
| 2019 FY | 3.58 Million USD | -29.0% |
| 2019 Q2 | 4.39 Million USD | -10.98% |
| 2019 Q3 | 3.97 Million USD | -9.54% |
| 2018 Q3 | 6.09 Million USD | -4.35% |
| 2018 Q2 | 6.37 Million USD | 0.34% |
| 2018 FY | 5.05 Million USD | -21.1% |
| 2018 Q1 | 6.35 Million USD | -0.8% |
| 2018 Q4 | 5.05 Million USD | -17.13% |
| 2017 Q2 | 7.25 Million USD | 3.91% |
| 2017 Q1 | 6.98 Million USD | -4.45% |
| 2017 FY | 6.4 Million USD | -12.36% |
| 2017 Q4 | 6.4 Million USD | -6.17% |
| 2017 Q3 | 6.82 Million USD | -5.93% |
| 2016 Q2 | 8.93 Million USD | -9.87% |
| 2016 Q1 | 9.91 Million USD | 2.63% |
| 2016 FY | 7.31 Million USD | -24.34% |
| 2016 Q4 | 7.31 Million USD | -14.69% |
| 2016 Q3 | 8.56 Million USD | -4.13% |
| 2015 FY | 9.66 Million USD | -36.93% |
| 2015 Q4 | 9.66 Million USD | -21.38% |
| 2015 Q3 | 12.29 Million USD | -9.79% |
| 2015 Q2 | 13.62 Million USD | -11.24% |
| 2015 Q1 | 15.34 Million USD | 0.18% |
| 2014 Q2 | 20.96 Million USD | -8.44% |
| 2014 Q4 | 15.32 Million USD | -19.42% |
| 2014 FY | 15.32 Million USD | -37.91% |
| 2014 Q1 | 22.89 Million USD | -7.23% |
| 2014 Q3 | 19.01 Million USD | -9.29% |
| 2013 Q1 | 33.26 Million USD | -8.52% |
| 2013 Q4 | 24.67 Million USD | -24.39% |
| 2013 FY | 24.67 Million USD | -32.13% |
| 2013 Q3 | 32.63 Million USD | -3.18% |
| 2013 Q2 | 33.71 Million USD | 1.35% |
| 2012 FY | 36.35 Million USD | 19.69% |
| 2012 Q1 | 34.32 Million USD | 12.99% |
| 2012 Q2 | 36.39 Million USD | 6.05% |
| 2012 Q3 | 37.81 Million USD | 3.89% |
| 2012 Q4 | 36.35 Million USD | -3.85% |
| 2011 Q4 | 30.37 Million USD | 14.11% |
| 2011 Q2 | 23.97 Million USD | 3.73% |
| 2011 Q3 | 26.62 Million USD | 11.03% |
| 2011 Q1 | 23.11 Million USD | 13.37% |
| 2011 FY | 30.37 Million USD | 49.0% |
| 2010 Q3 | 19.86 Million USD | 2.87% |
| 2010 Q2 | 19.3 Million USD | 21.89% |
| 2010 Q1 | 15.83 Million USD | 11.29% |
| 2010 FY | 20.38 Million USD | 43.25% |
| 2010 Q4 | 20.38 Million USD | 2.66% |
| 2009 FY | 14.23 Million USD | 8.32% |
| 2009 Q1 | 13.2 Million USD | 0.5% |
| 2009 Q2 | 14.87 Million USD | 12.63% |
| 2009 Q3 | 14.91 Million USD | 0.28% |
| 2009 Q4 | 14.23 Million USD | -4.58% |
| 2008 FY | 13.13 Million USD | -9.06% |
| 2008 Q2 | 14.97 Million USD | 1.13% |
| 2008 Q3 | 14.54 Million USD | -2.9% |
| 2008 Q4 | 13.13 Million USD | -9.65% |
| 2008 Q1 | 14.81 Million USD | 2.5% |
| 2007 Q4 | 14.44 Million USD | 5.34% |
| 2007 FY | 14.44 Million USD | 40.58% |
| 2007 Q3 | 13.71 Million USD | 10.69% |
| 2007 Q2 | 12.39 Million USD | 7.97% |
| 2007 Q1 | 11.47 Million USD | 11.66% |
| 2006 FY | 10.27 Million USD | 77.66% |
| 2006 Q4 | 10.27 Million USD | 20.18% |
| 2006 Q3 | 8.55 Million USD | 26.09% |
| 2006 Q2 | 6.78 Million USD | 3.55% |
| 2006 Q1 | 6.55 Million USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | 4.79 Million USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | 5.78 Million USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| cbdMD, Inc. | 4.05 Million USD | 7.857% |
| cbdMD, Inc. | 4.05 Million USD | 7.857% |
| Zomedica Corp. | 5.12 Million USD | 27.103% |